Cargando…

Clinical efficacy and tolerability of direct-acting antivirals in elderly patients with chronic hepatitis C

BACKGROUND: There is a lack of evidence-based data on aged patients with newer direct-acting antivirals (DAAs) and with shorter duration of treatment regimens involving DAAs with or without ribavirin (RBV) and pegylated interferon (Peg IFN). PATIENTS AND METHODS: Medical records of 240 patients trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sherigar, Jagannath M., Gayam, Vijay, Khan, Arifa, Mukhtar, Osama, Arefiev, Yavgeniy, Khalid, Mazin, Siddiqui, Imran, Rangaraju, Ayyappa M., Budhathoki, Nibash, Mansour, Mohammed, Guss, Debra, Mohanty, Smruti R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams And Wilkins 2017
Materias:	Original Articles: Hepatitis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459584/ https://www.ncbi.nlm.nih.gov/pubmed/28346233 http://dx.doi.org/10.1097/MEG.0000000000000871

Ejemplares similares

Seronegative Autoimmune Hepatitis A Clinically Challenging Difficult Diagnosis
por: Sherigar, Jagannath M., et al.
Publicado: (2017)

Direct-Acting Antivirals in Chronic Hepatitis C Genotype 4 Infection in Community Care Setting
por: Gayam, Vijay, et al.
Publicado: (2018)

Association Between Vitamin D Levels and Treatment Response to Direct-Acting Antivirals in Chronic Hepatitis C: A Real-World Study
por: Gayam, Vijay, et al.
Publicado: (2018)

Sofosbuvir based regimens in the treatment of chronic hepatitis C genotype 1 infection in African–American patients: a community-based retrospective cohort study
por: Gayam, Vijay, et al.
Publicado: (2018)

Real-World Clinical Efficacy and Tolerability of Direct-Acting Antivirals in Hepatitis C Monoinfection Compared to Hepatitis C/Human Immunodeficiency Virus Coinfection in a Community Care Setting
por: Gayam, Vijay, et al.
Publicado: (2018)

Missed Diagnosis of Liver Cirrhosis Leads to Disparities in Care for Older Patients
por: Guss, Debra, et al.
Publicado: (2018)

An Unusual Presentation of Glycogenic Hepatopathy with Bridging Fibrosis
por: Sherigar, Jagannath M., et al.
Publicado: (2018)

A delayed presentation of splenic laceration and hemoperitoneum following an elective colonoscopy: A rare complication with uncertain risk factors
por: Zhang, Allison N, et al.
Publicado: (2018)

Glycogenic hepatopathy: A narrative review
por: Sherigar, Jagannath M, et al.
Publicado: (2018)

Minimum target prices for production of direct-acting antivirals and associated diagnostics to combat hepatitis C virus
por: van de Ven, Nikolien, et al.
Publicado: (2015)

Peripheral neuropathy after viral eradication with direct‐acting antivirals in chronic HCV hepatitis: A prospective study
por: Zanone, Maria M., et al.
Publicado: (2021)

Over time evaluation of glycaemic control in direct‐acting antiviral‐treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis
por: Cacciola, Irene, et al.
Publicado: (2021)

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals
por: Martin, Natasha K, et al.
Publicado: (2013)

Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: A real‐world nationwide hepatitis C virus registry programme in Taiwan
por: Chen, Chi‐Yi, et al.
Publicado: (2021)

TEMPORAL TRENDS IN THE DETECTION RATES OF HEPATITIS B IN THE SANTA CATARINA STATE, BRAZIL
por: Marcon, Chaiana Esmeraldino Mendes, et al.
Publicado: (2014)

HEPATITIS B VACCINATION COVERAGE AND POSTVACCINATION SEROLOGIC TESTING AMONG MEDICAL STUDENTS AT A PUBLIC UNIVERSITY IN BRAZIL
por: de Souza, Eduardo Pernambuco, et al.
Publicado: (2014)

HCV INFECTION THROUGH PERFORATING AND CUTTING MATERIAL AMONG CANDIDATES FOR BLOOD DONATION IN BELÉM, BRAZILIAN AMAZON
por: Valois, Rubenilson Caldas, et al.
Publicado: (2014)

HIV AND HCV COINFECTION: PREVALENCE, ASSOCIATED FACTORS AND GENOTYPE CHARACTERIZATION IN THE MIDWEST REGION OF BRAZIL
por: Freitas, Solange Zacalusni, et al.
Publicado: (2014)

Viral quasispecies quantitative analysis: a novel approach for appraising the immune tolerant phase of chronic hepatitis B virus infection
por: Wang, Mingjie, et al.
Publicado: (2021)

Human hepatocyte-enriched miRNA-192-3p promotes HBV replication through inhibiting Akt/mTOR signalling by targeting ZNF143 in hepatic cell lines
por: Li, Fahong, et al.
Publicado: (2022)

Sexually-transmitted hepatitis C virus reinfections among people living with HIV in Taiwan: the emerging role of genotype 6
por: Chen, Guan-Jhou, et al.
Publicado: (2022)

Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection
por: Wang, Shao-Juan, et al.
Publicado: (2021)

A standardized assay for the quantitative detection of serum HBV RNA in chronic hepatitis B patients
por: Yu, Guangxin, et al.
Publicado: (2022)

Hepatitis C microelimination among people living with HIV in Taiwan
por: Chen, Guan-Jhou, et al.
Publicado: (2022)

Molecular epidemiology and genotype-specific disease severity of hepatitis E virus infections in Germany, 2010–2019
por: Schemmerer, Mathias, et al.
Publicado: (2022)

Intrahepatic transcriptomics reveals gene signatures in chronic hepatitis B patients responded to interferon therapy
por: Li, Ning, et al.
Publicado: (2022)

Role of S protein transmembrane domain mutations in the development of occult hepatitis B virus infection
por: Jiang, Xinyi, et al.
Publicado: (2022)

Compartmentalisation of Hepatitis B virus X gene evolution in hepatocellular carcinoma microenvironment and the genotype-phenotype correlation of tumorigenicity in HBV-related patients with hepatocellular carcinoma
por: Fu, Ya, et al.
Publicado: (2022)

Profile of clinical characteristics and serologic markers of sporadic hepatitis E in a community cohort study
por: Tang, Zi-Min, et al.
Publicado: (2022)

CRISPR/Cas13a-assisted rapid and portable HBV DNA detection for low-level viremia patients
por: Tian, Yuan, et al.
Publicado: (2023)

The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance
por: Jiang, Shaowen, et al.
Publicado: (2023)

Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial
por: Zhong, Guohua, et al.
Publicado: (2023)

Prevalence of antibody to hepatitis B surface antigen among qualified blood donors in Nanjing, China
por: Zhou, Yi-Hua, et al.
Publicado: (2023)

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
por: Piermatteo, Lorenzo, et al.
Publicado: (2023)

Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control
por: Yan, Bingyu, et al.
Publicado: (2023)

The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment
por: Yin, Shengxia, et al.
Publicado: (2023)

Enhanced monitoring and detection of recent genotype 3 hepatitis E virus infection through urine antigen testing
por: Stahl, Yannick, et al.
Publicado: (2023)

Knowledge and awareness of viral hepatitis and influencing factors among the general population aged 15–69 years in Zhejiang Province, China
por: Zhou, Yang, et al.
Publicado: (2023)

Hepatitis B virus promotes its own replication by enhancing RAB5A-mediated dual activation of endosomal and autophagic vesicle pathways
por: Zhao, Zhenyu, et al.
Publicado: (2023)

Immunogenicity persistence of hepatitis A vaccines Healive® and Havrix® among children:15 years follow-up and long-term prediction
por: Wang, Xiaoli, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nob2bie3l6pmj9336ii9skar00